Literature DB >> 1716026

The carboxy-terminal part of the NS 3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase.

G Wengler1, G Wengler1.   

Abstract

Recently it has been reported that a membrane fraction can be isolated from West Nile virus-infected BHK cells which contains the viral nonstructural (NS) proteins as major constituents (Wengler et al., 1990). In this report we show that treatment of these membranes with subtilisin releases the carboxy-terminal segment of the NS 3 protein as a soluble protein of about 50 kDa apparent molecular weight. This molecule, which is called the p50-S protein, can be purified by standard chromatographic procedures. The p50-S protein binds to poly(A) and apparently represents a nucleoside triphosphatase which is stimulated in the presence of ssRNA molecules. The data represent experimental support for the predicted role of this segment of the NS 3 protein as an RNA helicase. Some properties of the p50-S protein are described and a possible function of this protein segment during RNA synthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716026     DOI: 10.1016/0042-6822(91)90440-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  82 in total

1.  ATP binding and ATPase activities associated with recombinant rabbit hemorrhagic disease virus 2C-like polypeptide.

Authors:  M S Marín; R Casais; J M Alonso; F Parra
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis.

Authors:  Grigori G Prikhod'ko; Elena A Prikhod'ko; Alexander G Pletnev; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Inhibition of dengue virus RNA synthesis by an adenosine nucleoside.

Authors:  Yen-Liang Chen; Zheng Yin; Jeyaraj Duraiswamy; Wouter Schul; Chin Chin Lim; Boping Liu; Hao Ying Xu; Min Qing; Andy Yip; Gang Wang; Wai Ling Chan; Hui Pen Tan; Melissa Lo; Sarah Liung; Ravinder Reddy Kondreddi; Ranga Rao; Helen Gu; Handan He; Thomas H Keller; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

4.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication.

Authors:  Mark Tilgner; Pei-Yong Shi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Characterization of dengue virus resistance to brequinar in cell culture.

Authors:  Min Qing; Gang Zou; Qing-Yin Wang; Hao Ying Xu; Hongping Dong; Zhiming Yuan; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

7.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

8.  Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging.

Authors:  Gorben P Pijlman; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

9.  Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling.

Authors:  Jared D Evans; Christoph Seeger
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA.

Authors:  A A Khromykh; E G Westaway
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.